Stone House Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Stone House Investment Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.04K	Hold	16	–	–	﹤0.01%	661
2026 Q1	$2.7K	Buy	+16	New	+$2.74K	﹤0.01%	549
2025 Q3	–	Sell	-30	Closed	-$3.73K	–	743
2025 Q2	$3.73K	Hold	30	–	–	﹤0.01%	366
2025 Q1	$3.78K	Buy	+30	New	+$4.07K	﹤0.01%	342
2024 Q4	–	Sell	-29	Closed	-$4.29K	–	191
2024 Q3	$4.29K	Hold	29	–	–	﹤0.01%	284
2024 Q2	$4.04K	Hold	29	–	–	﹤0.01%	285
2024 Q1	$4.04K	Hold	29	–	–	﹤0.01%	299
2023 Q4	$4K	Hold	29	–	–	﹤0.01%	231
2023 Q3	$3.59K	Hold	29	–	–	﹤0.01%	224
2023 Q2	$3.73K	Hold	29	–	–	﹤0.01%	221
2023 Q1	$3.79K	Buy	+29	New	+$3.8K	﹤0.01%	213
2019 Q2	–	Sell	-243	Closed	-$27K	–	109
2019 Q1	$27K	Buy	+243	New	+$26.7K	0.01%	120

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Stone House Investment Management's IBB Position: Q2 2026 in Review

Stone House Investment Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 16 shares worth $3.04K. The position accounts for ﹤0.01% of the portfolio, ranked #661.

Stone House Investment Management first reported a position in IBB in Q1 2019 and has held it in 12 quarters since. The position peaked at $27K in Q1 2019. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Stone House Investment Management held 16 shares of iShares Biotechnology ETF worth $3.04K as of Q2 2026.
Stone House Investment Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up ﹤0.01% of Stone House Investment Management's portfolio in Q2 2026, its #661 holding.
Stone House Investment Management first reported a position in iShares Biotechnology ETF in Q1 2019 and has held it in 12 quarters since.
Stone House Investment Management's iShares Biotechnology ETF position peaked at $27K in Q1 2019.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.